Space, once the exclusive domain of astronauts, space stations, and satellites, is emerging as a critical enabler of pharmaceutical and biomedical innovation. As India shifts from a generics-led model to becoming a hub for high-value pharmaceutical innovation, microgravity research opens new frontiers in drug development, disease modeling, formulation science, and personalized medicine. These breakthroughs can potentially overcome long-standing R&D bottlenecks and fast-track safer, more effective, and more accessible solutions. Read more- https://www.ipa-india.org/article/space-the-final-frontier-for-research-in-pharma-and-biomedicine/